These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 23982252)

  • 21. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma.
    Kuo KT; Wang HW; Chou TY; Hsu WH; Hsu HS; Lin CH; Wang LS
    Ann Surg Oncol; 2009 Feb; 16(2):352-60. PubMed ID: 19050969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High expression of Y-box-binding protein-1 is associated with poor survival in resectable esophageal squamous cell carcinoma.
    Li Y; Wen ZS; Yang HX; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH
    Ann Surg Oncol; 2011 Nov; 18(12):3370-6. PubMed ID: 21630125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-stroma ratio is an independent predictor for survival in esophageal squamous cell carcinoma.
    Wang K; Ma W; Wang J; Yu L; Zhang X; Wang Z; Tan B; Wang N; Bai B; Yang S; Liu H; Zhu S; Cheng Y
    J Thorac Oncol; 2012 Sep; 7(9):1457-61. PubMed ID: 22843085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concordance of HER2 status in primary tumour and lymph node metastases in patients with esophageal carcinoma.
    König AM; Reeh M; Dancau AM; Rathjens M; Gros S; Uzunoglu FG; Bockhorn M; Simon R; Sauter G; Marx A; Izbicki JR
    Anticancer Res; 2013 Nov; 33(11):4975-82. PubMed ID: 24222138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
    Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
    Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma.
    Luo KJ; Wen J; Xie X; Fu JH; Luo RZ; Wu QL; Hu Y
    Ann Thorac Surg; 2012 May; 93(5):1682-8. PubMed ID: 22480390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T1 squamous cell carcinoma of the esophagus: long-term outcomes and prognostic factors after esophagectomy.
    Tanaka T; Matono S; Mori N; Shirouzu K; Fujita H
    Ann Surg Oncol; 2014 Mar; 21(3):932-8. PubMed ID: 24232603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
    Zhang Y; Liu YP; Du K; Wang H; Wang XL
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma.
    Zhang H; Chen W; Duan CJ; Zhang CF
    World J Surg Oncol; 2013 Jun; 11():141. PubMed ID: 23777267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of stromal caveolin-1 expression in colorectal cancer predicts poor survival.
    Zhao Z; Han FH; Yang SB; Hua LX; Wu JH; Zhan WH
    World J Gastroenterol; 2015 Jan; 21(4):1140-7. PubMed ID: 25632186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. κ-Opioid receptor in the nucleus is a novel prognostic factor of esophageal squamous cell carcinoma.
    Zhang YF; Xu QX; Liao LD; Xu XE; Wu JY; Shen J; Wu ZY; Shen JH; Li EM; Xu LY
    Hum Pathol; 2013 Sep; 44(9):1756-65. PubMed ID: 23574786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High phosphorylated 4E-binding protein 1 expression after chemoradiotherapy is a predictor for locoregional recurrence and worse survival in esophageal squamous cell carcinoma patients.
    Chao YK; Chuang WY; Yeh CJ; Chang YS; Wu YC; Kuo SY; Hsieh MJ; Hsueh C
    J Surg Oncol; 2012 Mar; 105(3):288-92. PubMed ID: 21932407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma.
    Wang LS; Chow KC; Lien YC; Kuo KT; Li WY
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):419-24. PubMed ID: 15296908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma.
    Gu ZD; Li JY; Li M; Gu J; Shi XT; Ke Y; Chen KN
    Am J Gastroenterol; 2005 Aug; 100(8):1835-43. PubMed ID: 16086722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis.
    Kato H; Nakajima M; Masuda N; Faried A; Sohda M; Fukai Y; Miyazaki T; Fukuchi M; Tsukada K; Kuwano H
    J Surg Oncol; 2005 May; 90(2):89-94. PubMed ID: 15844180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nodal skip metastasis is not a predictor of survival in thoracic esophageal squamous cell carcinoma.
    Zhu Z; Yu W; Li H; Zhao K; Zhao W; Zhang Y; Sun M; Wei Q; Chen H; Xiang J; Fu X
    Ann Surg Oncol; 2013 Sep; 20(9):3052-8. PubMed ID: 23686016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
    Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
    J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome.
    El-Gendi SM; Mostafa MF; El-Gendi AM
    Pathol Oncol Res; 2012 Apr; 18(2):459-69. PubMed ID: 22057638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.